🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The immediate release (IR) formulation of retigabine has been shown to be s...
Status
Terminated
Location
GSK Investigational Site
Start Date
2012-08-29
Trial ID
NCT01648101
Treatments Being Tested
The purpose of this Phase III study is to evaluate the efficacy, safety and...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07
Trial ID
NCT01227902
Treatments Being Tested
This is an open-label, single centre, repeat dose, up- titration study in h...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-10
Trial ID
NCT01332513
The purpose of this Phase III study is to assess the long-term safety, tole...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-21
Trial ID
NCT01336621
Treatments Being Tested
This is a Phase IV adjunctive treatment dose-optimization study evaluating ...
Status
Terminated
Location
GSK Investigational Site
Start Date
2012-12-19
Trial ID
NCT01721317
Treatments Being Tested
This is a multicentre, long-term, open-label extension (OLE) study to asses...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-04-11
Trial ID
NCT01777139
Treatments Being Tested